Abstract-Local anesthetic antiarrhythmic drugs block voltage-gated Na ϩ channels from the cytoplasmic side. In addition, cardiac Na ϩ channels can be also blocked by the membrane-impermeant local anesthetic QX via external paths not present in skeletal muscle or brain channels. Introduction of cardiac isoform-specific residues into wild-type skeletal muscle or brain channels creates access paths for external QX block. These paths should affect the characteristics of use-dependent block by influencing drug on-and off-rates. We investigated the effects of these external paths on drug kinetics of lidocaine, a lipophilic drug of clinical relevance, by studying use-dependent block using a two-electrode voltage clamp in Xenopus oocytes. Recovery from use-dependent block was slowed when cardiac isoform-specific residues important for external QX access were mutated to skeletal muscle or brain isoform-specific residues. As the fraction of charged lidocaine was decreased by raising external pH, differences in recovery kinetics diminished, indicating that these mutations mostly influenced block by charged lidocaine molecules. Data were fit into a model in which bound drug distributes into charged and neutral forms based on its pK a and external pH with separate dissociation paths and recovery-time constants. These isoform-specific mutations altered the recovery-time constants for the charged molecules with smaller effects on those for the neutral molecules. We conclude that the external egress paths created by isoform-specific residues influence the drug kinetics of lidocaine, and these residues define cardiac-specific external paths for local anesthetic drugs. block Na ϩ current by binding to voltage-gated Na ϩ channels. LA drugs in clinical use are tertiary amines and exhibit both tonic and use-dependent block (UDB) of Na ϩ current. UDB by LA drugs is the hallmark of their antiarrhythmic activity; it enables these drugs to be more effective when the frequency of action potentials is high such as in ventricular tachycardia. During UDB, blocked channels accumulate because of incomplete recovery of drug-bound channels during diastole. Slowed recovery of drug-bound channels can be explained by a combination of the modulated-receptor hypothesis 2,3 and the guarded-receptor model. 4,5 The modulated-receptor hypothesis proposes that higher affinity for LA drugs during activated and inactivated gating states slows unbinding of drug and, consequently, recovery of the drug-bound channels. The guarded-receptor model emphasizes that a statedependent availability of the drug access path to and from the binding site influences apparent binding and unbinding kinetics.LA drugs block Na ϩ channels by binding to a site within the pore below the selectivity filter and above the activation gate at the inner pore mouth. 6,7 Specific S6 residues from domains 1, 3, and 4 (D4S6) have been identified as parts of the binding site. 8 -11 Hille 2 has proposed two paths to and from the binding site, a fast hydrophobic path for neutral drug and a s...